The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression

Allergy and Asthma Proceedings

Volumn 31, Issue 5, 2010, Pages 407-414

  Lumry, William R ^a   Castaldo, Anthony J ^b   Vernon, Margaret K ^c   Blaustein, Marc B ^d   Wilson, David A ^e   Horn, Patrick T ^d  

^a AARA Research Center   (United States)

^b United States Hereditary Angioedema Association   (United States)

^c UNITED BIOSOURCE CORPORATION   (United States)

^d Dyax Corp   (United States)

^e MGH INSTITUTE OF HEALTH PROFESSIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANTIDEPRESSANT AGENT; PSYCHOTROPIC AGENT;

ABSENTEEISM; ACNE; ADULT; AGITATION; ANDROGEN THERAPY; ANGIONEUROTIC EDEMA; ARTICLE; ATTENTION DISTURBANCE; BLOOD CLOT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GROWTH RETARDATION; HAIR GROWTH; HEALTH SURVEY; HUMAN; INSOMNIA; INTERNET; JOB PERFORMANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MENSTRUAL IRREGULARITY; MOOD CHANGE; PAIN ASSESSMENT; PRACTICE GUIDELINE; QUALITY OF LIFE; QUESTIONNAIRE; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SIDE EFFECT; SOCIOECONOMICS; SOMNOLENCE; STUNTED GROWTH; VOICE CHANGE; WEIGHT GAIN;

ADULT; ANGIOEDEMAS, HEREDITARY; COST OF ILLNESS; DEPRESSION; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE;

EID: 77958102578     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3394     Document Type: Article

References (33)

1. Bowen T, Cicardi M, Bork K, et al. Hereditary angioedema: A current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 100(suppl 2):S30-S40, 2008.
2. Agostoni A, and Cicardi M. Hereditary and acquired C1-inhibitor deficiency: Biological and clinical characteristics in 235 patients. Medicine 71:206-215, 1992.
3. Gompels MM, Lock RJ, Abinun M, et al. C1 inhibitor deficiency: Consensus document. Clin Exp Immunol 139:379-394, 2005.
4. Bork K, Meng G, Staubach P, and Hardt J. Hereditary angioedema: New findings concerning symptoms, affected organs, and course. Am J Med 119:267-274, 2006. (Pubitemid 43255068)
5. Zuraw BL, and Christiansen SC. Pathogenesis and laboratory diagnosis of hereditary angioedema. Allergy Asthma Proc 30:487-492, 2009.
6. Bork K, and Ressel N. Sudden upper airway obstruction in patients with hereditary angioedema. Transfus Aphers Sci 29:235-238, 2003. (Pubitemid 37315588)
7. Roche O, Blanch A, Caballero T, et al. Hereditary angioedema due to C1 inhibitor deficiency: Patient registry and approach to the prevalence in Spain. Ann Allergy Asthma Immunol 94:498-503, 2005. (Pubitemid 40547939)
8. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med 359:1027-1036, 2008.
9. Agostoni A, Aygoren-Pursun E, Binkley KE, et al. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51-S131, 2004.
10. Nzeako UC, Frigas E, and Tremaine WJ. Hereditary angioedema, a broad review for clinicians. Arch Intern Med 161:2417-2429, 2001. (Pubitemid 33043115)
11. Kemp JG, and Craig TJ. Variability of prodromal signs and symptoms associated with hereditary angioedema attacks: A literature review. Allergy Asthma Proc 30:493-499, 2009.
12. Prematta MJ, Kemp JG, Gibbs JG, et al. Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. Allergy Asthma Proc 30:506-511, 2009.
13. Levy JH, and O'Donnell PS. The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema. Expert Opin Investig Drugs 15:1077-1090, 2006.
14. Bracho F. Hereditary angioedema. Curr Opin Hematol 12:493-498, 2005.
15. Davis AE, III. New treatments addressing the pathophysiology of hereditary angioedema. Clin Mol Allergy 6:2, 2008.
16. Frank MM, Gelfand JA, and Atkinson JP. Hereditary angioedema: The clinical syndrome and its management. Ann Intern Med 84:580-593, 1976.
17. Longhurst HJ, Carr S, and Khair K. C1-inhibitor concentrate home therapy for hereditary angioedema: A viable, effective treatment option. Clin Exp Immunol 147:11-17, 2007. (Pubitemid 44915550)
18. Zuraw BL. Diagnosis and management of hereditary angioedema: An American approach. Transfus Apher Sci 29:239-245, 2003. (Pubitemid 37321354)
19. Huang SW. Results of an on-line survey of patients with hereditary angioedema. Allergy Asthma Proc 25:127-131, 2004.
20. Bygum A, Andersen KE, and Mikkelsen CS. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. Eur J Dermatol 19:147-151, 2009.
21. Wilson DA, Bork K, Shea EP, et al. Economic costs associated with acute attacks and long-term management of hereditary angioedema. Ann Allergy Asthma Immunol 104:314-320, 2010.
22. Ware JE Jr, Kosinski M, Turner-Bowker D, and Gandek B. How to Score Version 2 of the SF-12 Health Survey (with a Supplement Documenting Version 1). Lincoln, RI: QualityMetric, Inc., 2002.
23. Reynolds WM, and Koback KA. HDI: Hamilton Depression Inventory Professional Manual. Lutz, FL: Psychological Assessment Resources, Inc., 1995.
24. Kobak KA, and Reynolds WM. The Hamilton depression inventory. In The Use of Psychological Testing for Treatment Planning and Outcomes Assessment, 3rd ed. Maruish ME (Ed). Mahwah, NJ: Routledge Taylor & Francis Group, 327-362, 2004.
25. Reilly MC, Zbrozek AS, and Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 4:353-365, 1993.
26. Paulose-Ram R, Safran MA, Jonas BS, et al. Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiol Drug Saf 16:560-570, 2007. (Pubitemid 46824278)
27. Chen H, Blanc PD, Hayden ML, et al. Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma. Value Health 11:231-239, 2008. (Pubitemid 351473606)
28. Reilly MC, Gerlier L, Brabant Y, and Brown M. Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease. Clin Ther 30:393-404, 2008. (Pubitemid 351474386)
29. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 31:596-615, 2008.
30. Banerji A, Sloane DE, and Sheffer AL. Hereditary angioedema: A current state-of-the-art review, V: Attenuated androgens for the treatment of hereditary angioedema. Ann Allergy Asthma Immunol 100(suppl 2):S19-S22, 2008.
31. Zuraw BL. Hereditary angioedema: A current state-of-the-art review, IV: Short- and long-term treatment of hereditary angioedema: Out with the old and in with the new? Ann Allergy Asthma Immunol 100(suppl 2):S13-S18, 2008.
32. Christiansen SC, and Zuraw BL. Update on therapeutic developments for hereditary angioedema. Allergy Asthma Proc 30:500-505, 2009.
33. Craig T, Riedl M, Dykewicz MS, et al. When is prophylaxis for hereditary angioedema necessary? Ann Allergy Asthma Immunol 102:366-372, 2009.